Skip to content
PoliticalRepoPoliticalRepo

Ireland · Question · written

PQ 414

414. Deputy Bríd Smith asked the Minister for Health if he will fast-track besremi reimbursement approval and call for an immediate reassessment of besremi by the NCPE given the current shortage of Pegasys; if he is aware that the NHS in England has approved besremi for interim use and that there is a clear precedent that could be followed to protect patient safety and continuity of care; his views on the case of a person (details supplied) who is desperate to secure besremi as an urgently needed treatment option; the measures they can take in the interim; and if he will make a statement on the matter. [45517/24]

askedIreland· Dáil Éireann· EN

Introduced

7 November 2024

Last action

Status

written

Sponsors

Subjects

Discovery layer

Source updated

7 November 2024

Summary

414. Deputy Bríd Smith asked the Minister for Health if he will fast-track besremi reimbursement approval and call for an immediate reassessment of besremi by the NCPE given the current shortage of Pegasys; if he is aware that the NHS in England has approved besremi for interim use and that there is a clear precedent that could be followed to protect patient safety and continuity of care; his views on the case of a person (details supplied) who is desperate to secure besremi as an urgently needed treatment option; the measures they can take in the interim; and if he will make a statement on the matter. [45517/24]

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

No timeline events have been ingested for this record yet.

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

1 official file

Medicinal Products

View fileDownload file

Sponsors

No sponsors or actors listed by the source.

Related records

No cross-record relationships stored yet.

Sources

PoliticalRepo is an index and interpretation layer, not the authoritative legal source.